You just read:

Mitsubishi Tanabe Pharma Corporation Group Announces Presentation of Patient-Reported Results from Phase 2 ND0612 Study at International Congress of Parkinson's Disease and Movement Disorders

News provided by

Mitsubishi Tanabe Pharma America, Inc.

Sep 23, 2019, 10:29 ET